Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCP1303 in BPH and ED
NCT02667938Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Mar 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tadalafil, tamsulosin in benign prostatic hyperplasia (BPH), erectile dysfunction (ED), sponsored by Hanmi Pharmaceutical. Started Mar 2015; status: completed.
02
Drugs
tadalafiltamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02667938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02667938.